CENTEVO levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

levodopa, Quantity: 200 mg; carbidopa monohydrate, Quantity: 54.1 mg (Equivalent: carbidopa, Qty 50 mg); entacapone, Quantity: 200 mg

Dostopno od:

Teva Pharma Australia Pty Ltd

INN (mednarodno ime):

carbidopa monohydrate,Entacapone,Levodopa

Farmacevtska oblika:

Tablet, film coated

Sestava:

Excipient Ingredients: microcrystalline cellulose; lactose; hyprolose; povidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; glycerol; iron oxide yellow; polysorbate 80; iron oxide red; iron oxide black

Pot uporabe:

Oral

Enote v paketu:

10, 28, 30, 50, 60, 90, 98, 100, 130, 150, 175, 200, 250

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

CENTEVO (Levodopa/carbidopa/entacapone) is indicated for the management of patients with Parkinson?s disease who are experiencing motor fluctuations.

Povzetek izdelek:

Visual Identification: Oblong, biconvex, brown tablet, marked with 200 on one side, plain on the other.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status dovoljenje:

Licence status A

Datum dovoljenje:

2016-04-07